|
MCPH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00189856411248E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.41980002702036E-09 |
| Normal-vs-Stage2 |
7.07780000053226E-07 |
| Normal-vs-Stage3 |
3.23080007191834E-10 |
| Normal-vs-Stage4 |
7.31680005472413E-09 |
| Stage1-vs-Stage2 |
4.832800E-01 |
| Stage1-vs-Stage3 |
1.271040E-01 |
| Stage1-vs-Stage4 |
1.039580E-01 |
| Stage2-vs-Stage3 |
6.943200E-01 |
| Stage2-vs-Stage4 |
4.644000E-01 |
| Stage3-vs-Stage4 |
6.588000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.19593265582807E-12 |
| Normal-vs-AfricanAmerican |
1.107730E-02 |
| Normal-vs-Asian |
4.03199999998716E-06 |
| Caucasian-vs-AfricanAmerican |
6.851800E-02 |
| Caucasian-vs-Asian |
5.580200E-01 |
| AfricanAmerican-vs-Asian |
2.309400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.24140031587672E-10 |
| Normal-vs-Female |
1.48659973220333E-10 |
| Male-vs-Female |
2.092000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.98880000024104E-07 |
| Normal-vs-Age(41-60Yrs) |
1.59660062948319E-11 |
| Normal-vs-Age(61-80Yrs) |
4.95349983253845E-10 |
| Normal-vs-Age(81-100Yrs) |
6.839600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.954100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.927700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.072600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.923200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.445400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.037200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.803600E-02 |
| Classical-VS-Follicular |
3.840400E-02 |
| Classical-VS-Other |
2.131200E-01 |
| Classical-VS-Normal |
5.60869994892244E-09 |
| Tall-VS-Follicular |
5.871400E-01 |
| Tall-VS-Other |
7.994600E-01 |
| Tall-VS-Normal |
2.52380000231867E-08 |
| Follicular-VS-Other |
6.141600E-01 |
| Follicular-VS-Normal |
4.8728000523468E-09 |
| Other-VS-Normal |
2.282900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.98639993342908E-11 |
| Normal-vs-N1 |
3.28320000075877E-08 |
| N0-vs-N1 |
3.912400E-01 |
|
|
